Related Experiment Video
Updated: Jun 18, 2026
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis
S J Miller1, Z D Lan, A Hardiman
1Department of Pediatrics, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Cincinnati, OH 45229-3039, USA.
Abstract:
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas without effective therapeutics. Bioinformatics was used to identify potential therapeutic targets. Paired Box (PAX), Eyes Absent (EYA), Dachsund (DACH) and Sine Oculis (SIX) genes, which form a regulatory interactive network in Drosophila, were found to be dysregulated in human MPNST cell lines and solid tumors. We identified a decrease in DACH1 expression, and increases in the expressions of PAX6, EYA1, EYA2, EYA4, and SIX1-4 genes. Consistent with the observation that half of MPNSTs develop in neurofibromatosis type 1 (NF1) patients, subsequent to NF1 mutation, we found that exogenous expression of the NF1-GTPase activating protein-related domain normalized DACH1 expression. EYA4 mRNA was elevated more than 100-fold as estimated by quantitative real-time PCR in most MPNST cell lines. In vitro, suppression of EYA4 expression using short hairpin RNA reduced cell adhesion and migration and caused cellular necrosis without affecting cell proliferation or apoptotic cell death. MPNST cells expressing shEYA4 either failed to form tumors in nude mice or formed very small tumors, with extensive necrosis but similar levels of proliferation and apoptosis as control cells. Our findings identify a role of EYA4 and possibly interacting SIX and DACH proteins in MPNSTs and suggest the EYA4 pathway as a rational therapeutic target.
Insights
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive cancers. Researchers found the Eyes Absent (EYA4) gene pathway is dysregulated in MPNSTs, suggesting it as a potential therapeutic target for these challenging sarcomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with limited therapeutic options.
- Dysregulation of developmental gene networks is implicated in MPNST pathogenesis.
- Neurofibromatosis type 1 (NF1) is associated with a significant proportion of MPNST cases.
Purpose of the Study:
- To identify potential therapeutic targets for MPNSTs using bioinformatics.
- To investigate the role of the Paired Box (PAX), Eyes Absent (EYA), Dachsund (DACH), and Sine Oculis (SIX) gene network in MPNSTs.
- To evaluate EYA4 as a potential therapeutic target in MPNSTs.
Main Methods:
- Bioinformatic analysis of gene expression in MPNST cell lines and tumors.
- Quantitative real-time PCR to measure EYA4 mRNA levels.
- Short hairpin RNA (shRNA) to suppress EYA4 expression in vitro and in vivo.
- Xenograft mouse models to assess tumor formation and growth.
Main Results:
- Dysregulation of PAX, EYA, DACH, and SIX genes was observed in MPNSTs, with decreased DACH1 and increased EYA family members, including EYA4.
- NF1 mutation correction normalized DACH1 expression.
- EYA4 mRNA levels were significantly elevated in MPNST cell lines.
- Suppression of EYA4 reduced MPNST cell adhesion and migration, induced necrosis, and inhibited tumor formation in mice.
Conclusions:
- The EYA4 pathway, potentially interacting with SIX and DACH proteins, plays a critical role in MPNST progression.
- EYA4 represents a promising and rational therapeutic target for MPNSTs.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Related Concept Videos
02:23Abnormal Proliferation
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...